Stock EVG THERACRYF PLC
Add to a list
To use this feature you must be a member
Log inSign up

News Theracryf Plc

Equities

EVG

GB00BSVYN304

Market Closed - London S.E.
Other stock markets
 11:35:01 2024-04-26 am EDT 		5-day change 1st Jan Change
0.8 GBX 0.00% Intraday chart for Theracryf Plc +3.23% -50.00%
Apr. 26 Evgen Pharma plc will Change its Ticker to TCF from EVG CI
Apr. 26 Evgen Pharma plc will Change its Name to TheraCryf plc CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Evgen Pharma plc will Change its Ticker to TCF from EVG
CI
Evgen Pharma plc will Change its Name to TheraCryf plc
CI
Norcros sells Johnson Tiles UK; Trifast trading well
AN
Northcoders launches bootcamp; Schroder invests
AN
Evgen Pharma Concludes Retail Offer of Shares
MT
Evgen Pharma plc - Retail Offer
AQ
Evgen Pharma plc - Acquisition, Fundraising and Change of Name
AQ
Evgen Pharma Signs Takeover Deal with Chronos Therapeutics; Raises Capital Via Share Issue, Subscription
MT
EARNINGS AND TRADING: Ten Lifestyle sees profit up but sales flat
AN
Evgen Pharma plc agreed to acquire Chronos Therapeutics Ltd. from group of shareholders for £3.4 million.
CI
Evgen Pharma finds evidence of SFX-01 activity in colon cancer models
AN
Evgen Pharma plc Announces That the Laboratories of Professor Grace Chen, Associate Professor Justin Colacino, and Professor Duxin Sun At the University of Michigan, Usa Have Observed Activity of Sfx-01 in Models of Colon Cancer
CI
Evgen Pharma plc - Positive update on SFX-01 in vitro Glioblastoma studies
AQ
Evgen Pharma shares up on studies into SFX-01 product progressing well
AN
Evgen Pharma plc Announces That the Laboratory of Dr Marjolein Geurts, Neuro-Oncologist At the Erasmus University Medical Centre Has Observed Continuing Activity of Sfx-01 in Gbm Cells
CI
Apax opts against lifting offer; DCI enters loan deal
AN
FTSE 100 falls at end of tepid week
AN
Evgen Pharma Issues Notice of Dispute to Stalicla Over Missed Milestone Payment
MT
Evgen partner raises USD17.4 million to support pipeline
AN
Evgen Pharma plc announced that it has received $17.4 million in funding from Stalicla SA
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. EVG Stock
  4. News Theracryf Plc